For Immediate Release
Unprecedented Impact Factor Growth for Mary Ann Liebert, Inc. Journals
Contact: Kathryn Ryan
914-740-2250
kryan@liebertpub.com
New Rochelle, NY, June 30, 2021—Mary Ann Liebert, Inc., publishers announces unprecedented growth in the impact factors of its peer-reviewed journals, as reported in the new 2020 Journal Citation Reports (Clarivate, 2021). 90% of the company’s journals increased in impact factor, and the portfolio of indexed journals now has the highest average impact factor in the history of the company. 75% of the company’s journals saw double-digit increases.
Standouts in the portfolio include Antioxidants and Redox Signaling, with a new impact factor of 8.401, Soft Robotics, with an historic 31% increase and new impact factor of 8.071, Thyroid, with an increase of 24% and new impact factor of 6.568, Tissue Engineering: Reviews with a new impact factor of 6.389, Diabetes Technology & Therapeutics with a 39% increase and new impact factor of 6.118, and The CRISPR Journal, with a new impact factor of 6.071.
Cannabis and Cannabinoid Research received a groundbreaking first impact factor of 5.764
“We are thrilled to see the continued impact our journals have in the scientific community,” said Vicki Cohn, Chief Editorial Officer of Mary Ann Liebert, Inc. “It is a tribute to the achievements and contributions of our authors, editors, editorial boards, and reviewers.”
Additional accomplishments include:
- Human Gene Therapy with a 26% increase and new impact factor of 5.695,
- Nucleic Acid Therapeutics with a new impact factor of 5.486,
- 3D Printing and Additive Manufacturing with an incredible 52% increase and new impact factor of 5.449,
- Journal of Neurotrauma with a 30% increase and new impact factor of 5.269,
- AIDS Patient Care and STDs with a 34% increase and new impact factor of 5.078,
- Advances in Wound Care with a 52% increase and new impact factor of 4.730, and
- LGBT Health with a 27% increase and new impact factor of 4.151.
About the Publisher
Mary Ann Liebert, Inc. is a leading independent publisher known worldwide for its prescience and establishment of authoritative peer-reviewed journals, books, and trade publications in cutting-edge fields such as biotechnology and regenerative medicine, biomedical research, medicine and surgery, public health research and policy, technology and engineering, law and policy, environmental research and policy, and other specialized disciplines. The company publishes over 100 peer-reviewed journals, leading trade magazines, and specialized newsletters which make critical contributions in advancing research and facilitating collaboration throughout the world in academia, industry, and government.